luxe pharma limited
luxe pharma limited Company Information
Group Structure
View All
Industry
Other human health activities
Registered Address
329 desborough avenue, high wycombe, HP11 2TH
Website
-luxe pharma limited Estimated Valuation
Pomanda estimates the enterprise value of LUXE PHARMA LIMITED at £26.8k based on a Turnover of £62.8k and 0.43x industry multiple (adjusted for size and gross margin).
luxe pharma limited Estimated Valuation
Pomanda estimates the enterprise value of LUXE PHARMA LIMITED at £0 based on an EBITDA of £-3.6k and a 3.14x industry multiple (adjusted for size and gross margin).
luxe pharma limited Estimated Valuation
Pomanda estimates the enterprise value of LUXE PHARMA LIMITED at £0 based on Net Assets of £-3.6k and 2.46x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Luxe Pharma Limited Overview
Luxe Pharma Limited is a live company located in high wycombe, HP11 2TH with a Companies House number of 14705577. It operates in the other human health activities sector, SIC Code 86900. Founded in March 2023, it's largest shareholder is danyal qureshi with a 100% stake. Luxe Pharma Limited is a startup, micro sized company, Pomanda has estimated its turnover at £62.8k with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Luxe Pharma Limited Health Check
Pomanda's financial health check has awarded Luxe Pharma Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 6 areas for improvement. Company Health Check FAQs
2 Strong
1 Regular
6 Weak
Size
annual sales of £62.8k, make it smaller than the average company (£727.5k)
- Luxe Pharma Limited
£727.5k - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Luxe Pharma Limited
- - Industry AVG
Production
with a gross margin of 22.3%, this company has a higher cost of product (38.6%)
- Luxe Pharma Limited
38.6% - Industry AVG
Profitability
an operating margin of -5.7% make it less profitable than the average company (5%)
- Luxe Pharma Limited
5% - Industry AVG
Employees
with 1 employees, this is below the industry average (19)
- Luxe Pharma Limited
19 - Industry AVG
Pay Structure
on an average salary of £26.5k, the company has an equivalent pay structure (£26.5k)
- Luxe Pharma Limited
£26.5k - Industry AVG
Efficiency
resulting in sales per employee of £62.8k, this is more efficient (£45.5k)
- Luxe Pharma Limited
£45.5k - Industry AVG
Debtor Days
it gets paid by customers after 47 days, this is later than average (20 days)
- Luxe Pharma Limited
20 days - Industry AVG
Creditor Days
its suppliers are paid after 86 days, this is slower than average (18 days)
- Luxe Pharma Limited
18 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Luxe Pharma Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Luxe Pharma Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 137.7%, this is a higher level of debt than the average (22.3%)
137.7% - Luxe Pharma Limited
22.3% - Industry AVG
LUXE PHARMA LIMITED financials
Luxe Pharma Limited's latest turnover from March 2024 is estimated at £62.8 thousand and the company has net assets of -£3.6 thousand. According to their latest financial statements, we estimate that Luxe Pharma Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | |
|---|---|
| Turnover | |
| Other Income Or Grants | |
| Cost Of Sales | |
| Gross Profit | |
| Admin Expenses | |
| Operating Profit | |
| Interest Payable | |
| Interest Receivable | |
| Pre-Tax Profit | |
| Tax | |
| Profit After Tax | |
| Dividends Paid | |
| Retained Profit | |
| Employee Costs | |
| Number Of Employees | |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | |
|---|---|
| Tangible Assets | 1,289 |
| Intangible Assets | |
| Investments & Other | |
| Debtors (Due After 1 year) | |
| Total Fixed Assets | 1,289 |
| Stock & work in progress | |
| Trade Debtors | 8,191 |
| Group Debtors | |
| Misc Debtors | |
| Cash | |
| misc current assets | |
| total current assets | 8,191 |
| total assets | 9,480 |
| Bank overdraft | |
| Bank loan | |
| Trade Creditors | 11,611 |
| Group/Directors Accounts | |
| other short term finances | |
| hp & lease commitments | |
| other current liabilities | |
| total current liabilities | 11,611 |
| loans | |
| hp & lease commitments | |
| Accruals and Deferred Income | 1,440 |
| other liabilities | |
| provisions | |
| total long term liabilities | 1,440 |
| total liabilities | 13,051 |
| net assets | -3,571 |
| total shareholders funds | -3,571 |
| Mar 2024 | |
|---|---|
| Operating Activities | |
| Operating Profit | |
| Depreciation | |
| Amortisation | |
| Tax | |
| Stock | |
| Debtors | 8,191 |
| Creditors | 11,611 |
| Accruals and Deferred Income | 1,440 |
| Deferred Taxes & Provisions | |
| Cash flow from operations | |
| Investing Activities | |
| capital expenditure | |
| Change in Investments | |
| cash flow from investments | |
| Financing Activities | |
| Bank loans | |
| Group/Directors Accounts | |
| Other Short Term Loans | |
| Long term loans | |
| Hire Purchase and Lease Commitments | |
| other long term liabilities | |
| share issue | |
| interest | |
| cash flow from financing | |
| cash and cash equivalents | |
| cash | |
| overdraft | |
| change in cash |
luxe pharma limited Credit Report and Business Information
Luxe Pharma Limited Competitor Analysis
Perform a competitor analysis for luxe pharma limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in HP11 area or any other competitors across 12 key performance metrics.
luxe pharma limited Ownership
LUXE PHARMA LIMITED group structure
Luxe Pharma Limited has no subsidiary companies.
Ultimate parent company
LUXE PHARMA LIMITED
14705577
luxe pharma limited directors
Luxe Pharma Limited currently has 1 director, Mr Danyaal Qureshi serving since Mar 2023.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Danyaal Qureshi | England | 28 years | Mar 2023 | - | Director |
P&L
March 2024turnover
62.8k
0%
operating profit
-3.6k
0%
gross margin
22.3%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
-3.6k
0%
total assets
9.5k
0%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
luxe pharma limited company details
company number
14705577
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
March 2023
age
2
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
March 2024
previous names
N/A
accountant
I SUMAR & CO LTD
auditor
-
address
329 desborough avenue, high wycombe, HP11 2TH
Bank
-
Legal Advisor
-
luxe pharma limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to luxe pharma limited.
luxe pharma limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for LUXE PHARMA LIMITED. This can take several minutes, an email will notify you when this has completed.
luxe pharma limited Companies House Filings - See Documents
| date | description | view/download |
|---|
